The Boston Retinal Implant Project has developed a subretinal, hermetically-enclosed, chronically-implantable vision prosthesis to restore some useful vision to people with degenerative retinal diseases, especially retinitis pigmentosa and age-related macular degeneration. The prosthesis offers advantages over the competing epiretinal devices by providing a lower risk of eye infection, reduced erosion through the delicate tissues that cover the front of the eye (i.e. the conjunctiva), and the ability to place stimulating electrodes closer to retinal nerve cells.

Commercial Partner

• Bionic Eye Technologies

  Ithaca, NY, USA